Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01271790

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 144 locations
View Trial Details
Completed

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

NCT01356160

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tucson, Arizona, United States
  • Beverly Hills, California, United States
  • Coronado, California, United States
  • Costa Mesa, California, United States
View all 23 locations
View Trial Details
Completed

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01225380

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 114 locations
View Trial Details
Completed

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

NCT00552240

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1512.28 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1100.1512.20 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1100.1512.15 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 1100.1512.26 Boehringer Ingelheim Investigational Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

NCT00389207

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1470.54004 Boehringer Ingelheim Investigational Site Capital Federal, Argentina
  • 1100.1470.54002 Boehringer Ingelheim Investigational Site Córdoba, Argentina
  • 1100.1470.54003 Boehringer Ingelheim Investigational Site Mar del Plata, Argentina
  • 1100.1470.54001 Boehringer Ingelheim Investigational Site Rosario, Argentina
View all 68 locations
View Trial Details
Completed

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

NCT00987337

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Coronado, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
View all 77 locations
View Trial Details

Related conditions